International Flavors & Fragrances Stock Slides 11% Over 7 Straight Down Days
A multi-day slide in the specialty chemicals maker prompts a closer look at the numbers behind the stock’s momentum.
International Flavors & Fragrances Inc. (IFF) manufactures and sells cosmetic, active, and natural health ingredients for use in various consumer products. The market has now pushed its stock LOWER for 7 consecutive trading days, a cumulative loss of 10.9% that has erased about $2.3 billion from the company’s market value.
The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products.
The Streak Next To The S&P 500
Here is how IFF stock stacks up against the S&P 500 over the streak and the periods around it:
- Micron Stock Offers More Than Market Momentum
- Tesla Stock And The Growth Question Mark
- What Intel Stock Was Saying Before Its 5x Climb
- TechnipFMC Stock Rides A 8-Day Winning Streak To A 15% Gain
- Marathon Petroleum Stock Climbs 14% On A 5-Day Winning Streak
- 5 Red Days In A Row: Arrowhead Pharmaceuticals Stock Is Down 17%
| Return Period | IFF | S&P 500 |
|---|---|---|
| 1D | -0.6% | 0.4% |
| 7D (Current Streak) | -10.9% | 0.8% |
| 1M (21D) | -3.2% | 2.0% |
| 3M (63D) | 4.7% | 9.5% |
| YTD 2026 | 12.0% | 10.2% |
| 2025 | -18.4% | 16.4% |
| 2024 | 6.3% | 23.3% |
| 2023 | -19.5% | 24.2% |
What Do the Fundamentals Say About This Sell-Off?
The move appears to be specific to the company, not the broader market. Over the same 7 trading days, the S&P 500 returned +0.8%. A look at the underlying business shows areas of strain when compared to market medians. Revenue over the last twelve months declined 5.6%, while the S&P 500 median saw revenue growth of 7.5%.
That pressure is also visible in profitability. Its operating margin over the last twelve months is 7.9%, measured against an S&P 500 median of 18.4%. While the streak is notable, it is not entirely unique in the current market; across the S&P 500, 33 stocks are on losing streaks of 3 days or more.
So How Should I Think About a Streak Like This?
A streak is not a signal to buy or sell. It is a measure of sustained attention and momentum, forcing a question: Does the business reality justify the new price? The data here offers a starting point for that analysis.
The market is pricing in a 10.9% decline over seven days against a backdrop of shrinking revenue and thinner margins than the median S&P 500 company. The disciplined next step is to weigh those facts for yourself.
A slide like this always poses the same follow-up: which marked-down stocks are actually worth buying? Our Buy the Dip screen runs that test every day, flagging beaten-down names whose fundamentals still hold up.
Those watching the group rather than this one name have another route: a materials ETF like XLB owns the whole group. That way, no single company’s next surprise decides the outcome.
IFF Has Fallen 57% From A Peak Before
A stock that falls day after day is a live lesson in what single-name exposure feels like. IFF itself has fallen 57% from a peak within the past five years, and a fall like that lands very differently when one position carries too much of your wealth. Knowing what a repeat would do to your net worth is exactly what the Trefis Wealth team computes, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.